SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysis.

Mavrakanas, Thomas A; Tsoukas, Michael A; Brophy, James M; Sharma, Abhinav; Gariani, Karim

Mavrakanas, Thomas A; Tsoukas, Michael A; Brophy, James M; Sharma, Abhinav; Gariani, Karim.

Affiliation

Mavrakanas TA; Division of Nephrology, Department of Medicine, McGill University Health Center Research Institute|CORE|Office 2B.44, 5252 de Maisonneuve West, Montreal, QC, H4A 3S9, Canada. thomas.mavrakanas@mcgill.ca.
Tsoukas MA; Division of Endocrinology, McGill University Health Centre, Montreal, QC, Canada.
Brophy JM; Division of Cardiology, McGill University Health Centre, Montreal, QC, Canada.
Sharma A; Division of Cardiology, McGill University Health Centre, Montreal, QC, Canada.
Gariani K; Division of Endocrinology, Diabetes, Nutrition and Patient Therapeutic Education, Geneva University Hospitals, Geneva, GE, Switzerland.

Sci Rep ; 13(1): 15922, 2023 09 23.

Article de En | MEDLINE | ID: mdl-37741858

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insuffisance rénale chronique / Atteinte rénale aigüe / Inhibiteurs du cotransporteur sodium-glucose de type 2 / Défaillance cardiaque Type d'étude: Clinical_trials / Etiology_studies / Systematic_reviews Limites: Humans Langue: En Journal: Sci Rep Année: 2023 Type de document: Article Pays d'affiliation: Canada Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google